Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GLP-1
MedTech
Fractyl pivots T2D therapy to obesity & GLP-1s, lays off staff
The company will instead pitch its outpatient procedure as an “off-ramp” for people looking to stop taking GLP-1s and maintain their weight loss.
Conor Hale
Jan 31, 2025 11:45am
Metsera eyes $289M IPO to fund phase 3 weight loss trial
Jan 27, 2025 11:00am
Novo links next-gen obesity drug to 22% weight loss at Week 36
Jan 24, 2025 6:51am
Obesity biotech Metsera files for a swift IPO
Jan 11, 2025 9:05am
Verdiva launches with $410M, weekly-dosed oral GLP-1 candidate
Jan 9, 2025 2:00am
Metsera links GLP-1 drug to 11% weight loss after 12 weeks
Jan 7, 2025 8:32am